>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance
:
  • NVTA -4.5%, MOH -4.1%, NVMI -2.3%, G -1.9%, PEP -0.5%
Other news:
  • DARE -31.2% (announces intent to offer primary shares of its common stock and warrants to purchase shares of its common stock)
  • HMNY -20.5% (commences best efforts underwritten public offering to issue and sell shares of its common stock and warrants to purchase shares of its common stock; size not disclosed)
  • AFMD -8.2% (commences an underwritten public offering of its common shares)
  • HSIC -6.5% (Federal Trade Commission filed a complaint against the nation's three largest dental supply companies)
  • PDCO -5.7% (Federal Trade Commission filed a complaint against the nation's three largest dental supply companies)
  • PACB -3.9% (commences common stock offering)
  • GLUU -1.9% (pulling back after 13% move higher)
  • TEVA -1.9% (trading lower in response after NVS received FDA approval for Glatopa)
  • COGT -1.7% (announced its plan to spin-off its data and analytics business, Red Violet, earlier than previously anticipated)
Analyst comments:
  • N/A.

>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance
:
  • WMIH +63.3%, GNC +36%, TYHT +29%, DAC +15.4%, UAA +12.4%, RNG +9.2%, QTNA+8.5%, WB +7.1%, VIPS +6.8%, APRN +6.3%, SREV +6.1%, (signs multi-year contract extensions with two long-standing technology clients), VECO +4.6%, DBD +4.5%, VRNS+3.9%, QLYS +3.4%, CHGG +3.3%, NRZ +3.2%, SQNS +2.6%, DNB +2.1%, FMC +2%, AMKR+1.3%, BRX +1.2%, ONDK +1.1%, AB +1%
M&A news:
  • CRVP +22.2% (Cott announces agreement to acquire Crystal Rock Holdings for approx $35 mln)
  • ABC +12.3% (AmerisourceBergen: Walgreens (WBA) has made an offer to acquire ABC, according to WSJ)
  • HDNG +8.3% (Hardinge to be acquired by Privet Fund Management for $18.50 per share in cash)
Other news:
  • VRTX +3.3% (announces FDA approval of FDA SYMDEKO to treat the underlying cause of Cystic Fibrosis in people ages 12 and older with certain mutations in the CFTR gene-to begin shipping to pharmacies this week)
  • CBIO +2.9% (announces proposed public offering of common stock)
  • DNR +2.9% (reports Q4 production was 61,144 barrels of oil equivalent per day; 2018 development capital budget is $300-325 million)
  • CLLS +2.6% (granted 2 patents for CRISPR Use in T-Cells in the US)
  • GRA +0.6% (CEO/Chairman discloses the purchase of 25k shares)
Analyst comments:
  • CBAY +6.1% (initiated with a Outperform at Evercore ISI)
  • ICHR +4.6% (upgraded to Strong Buy from Buy at Needham)
  • ADT +4.1% (initiated with a Buy at Goldman, among others)
  • NTAP +3% (upgraded to Buy from Neutral at BofA/Merrill; upgraded to Buy from Hold at Loop Capital)
  • ADI +1.7% (upgraded to Overweight from Neutral at Piper Jaffray)
  • NINE +1.7% (initiated with a Overweight at JP Morgan; initiated with a Buy at BofA/Merrill)
  • FRAC +1.4% (upgraded to Buy from Neutral at Citigroup)
  • HIIQ +1.1% (initiated with a Buy at B. Riley FBR)
  • CELG +1% (upgraded to Overweight from Equal Weight at Barclays)
  • MMM +0.9% (upgraded to Buy from Hold at Deutsche Bank)
  • TOT +0.8% (upgraded to Overweight from Equal-Weight at Morgan Stanley; upgraded to Strong Buy at Raymond James)

>>> US Early premarket gappers

Early premarket gappers
Gapping up:

GNC +33.7%, TYHT +31%, WMIH +28.1%, KDMN +24%, CRVP +22.2%, ABC +18.5%, DAC +15.4%, RNG +9.2%, QTNA +8.5%, HDNG +6.6%, SREV +6.1%, VIPS +6%, WB +5.2%, CHGG +5.1%, VECO +4.6%, VRNS +3.9%, QLYS +3.4%, DNR +2.9%, HMY +2.7%, CLLS +2.3%, DNB +2.1%, VRTX +2%, UAA +1.5%, AMKR +1.3%, BRX +1.2%, HIIQ +1.1%, AB +1%, BHP +0.9%, FMC +0.9%, PEP +0.8%, ONCE +0.7%
Gapping down:

DARE -26.5%, HMNY -17.9%, AFMD -14.3%, HSIC -5.4%, PDCO -5.3%, NVTA -4.5%, MOH -4.1%, PACB -3.9%, FENG -3.5%, CBIO -3.4%, NVMI -2.3%, GLUU -1.9%, TER -1.9%, G -0.9

>>> Under Armour reports EPS in-line, beats on revs; guides FY18 EPS below conse

Under Armour reports EPS in-line, beats on revs; guides FY18 EPS below consensus, rev in-line (14.23)
  • Reports Q4 (Dec) net of breakeven, excluding non-recurring items, in-line with the Capital IQ Consensus of ($0.00); revenues rose 4.6% year/year to $1.37 bln vs the $1.31 bln Capital IQ Consensus (up 4 percent currency neutral).
    • Revenue to wholesale customers declined 1 percent to $733 million and direct-to-consumer revenue was up 11 percent to $575 million. Direct-to-consumer represented 42 percent of global revenue in the quarter.
    • Consistent with previous expectations, revenue in North America was down 4 percent. Strong international momentum continued with revenue up 47 percent (up 43 percent currency neutral), representing 23 percent of total revenue. Within our international business, revenue in EMEA was up 45 percent (up 37 percent currency neutral), up 56 percent in Asia-Pacific (up 55 percent currency neutral) and up 36 percent in Latin America (up 34 percent currency neutral).
    • Apparel revenue increased 2 percent to $952 million, as growth in men's training and global football was tempered by declines in the team sports and outdoor categories. Footwear revenue was up 9 percent to $246 million, driven by strength in running, offset by team sports and basketball. Accessories revenue increased 6 percent to $111 million led by men's training and running.
  • Co issues downside guidance for FY18, sees EPS of $0.14-0.19, excluding non-recurring items, vs. $0.22 Capital IQ Consensus. Net revenue is expected to be up at a low single-digit percentage rate (vs. +3.3% consensus) reflecting a mid-single-digit decline in North America and international growth of greater than 25 percent. Gross margin is expected to increase ~50 basis points to 45.5 percent due to benefits from lower planned promotional activity, product costs, channel mix and changes in foreign currency. Operating income is expected to reach $20 million to $30 million. Excluding the impact of continued restructuring efforts, adjusted operating income is expected to be $130 to $160 million.
  • Based on the restructuring efforts in 2017 and 2018, the company anticipates a minimum of $75 million in savings annually from these efforts in 2019 and beyond.

LA Tribune : Privatisation d'ADP : le casse-tête des actionnaires minoritaires

Privatisation d'ADP : le casse-tête des actionnaires minoritaires

Selon plusieurs observateurs, le droit exclusif dont dispose ADP pour exploiter les aéroports parisiens, sans limitation de durée, est incompatible avec une privatisation. Si elle était décidée, celle-ci ne pourrait passer que par l'instauration d'une concession de très longue durée. Problème, ce changement de régime impacterait la valeur d'ADP et pénaliserait les actionnaires minoritaires qu'il faudrait indemniser. Cette charge peut incomber à l'État ou à un nouvel acquéreur par le biais du lancement d'une offre publique d'achat. Or ce point suppose que l'État, qui possède aujourd'hui 50,6 % du capital, cède un bloc d'actions d'au moins 30 % du capital, le seuil à partir duquel un actionnaire doit lancer une OPA sur l'ensemble du capital.

Étudiée par l'État, la privatisation d'ADP, le gestionnaire des aéroports parisiens, tourne au casse-tête pour l'Agence des participations de l'État (APE). Sans même parler de la question de l'opportunité ou pas de privatiser des actifs stratégiques pour le pays qui promet de beaux débats au Parlement au moment où le processus législatif de la privatisation sera effectif, se pose celle de confier à un acteur privé l'exploitation éternelle d'un monopole de fait.
Un droit d'exploitation éternel est incompatible avec une privatisation

En effet, depuis la loi de 2005 relative aux aéroports, ADP dispose d'un droit exclusif pour l'exploitation des aéroports de Roissy, d'Orly et du Bourget sans limitation de durée. Si cette question de l'éternité de l'exploitation d'un actif en situation de monopole ne pose pas de problème quand l'État reste aux manettes du groupe, comme c'est le cas aujourd'hui avec les 50,6 % du capital qu'il détient, elle devient problématique quand l'actif en question est privatisée comme ce sera le cas demain si l'État vend tout ou partie d'ADP. D'autant plus qu'ADP est propriétaire de l'ensemble de son foncier.

Ce point a été souligné la semaine dernière par Xavier Huillard, le PDG du groupe Vinci, donné favori en cas de privatisation d'ADP.

« Le vrai sujet est qu'ADP jouit d'un droit d'exploitation éternel. Certains pensent que cela ne pose pas de problème tant que l'État détient plus de 50 % du capital, mais qu'en passant sous la barre des 50 %, il y a une contradiction constitutionnelle entre le droit d'exploitation éternel et le fait que l'État ne soit plus en position de contrepoids », a indiqué Xavier Huillard à quelques journalistes, en aparté de la conférence de presse présentant les résultats annuels.

Selon certains observateurs, cette éternité se heurterait au droit européen de la commande publique mais aussi, en France, aux principes généraux du droit de la commande publique du Conseil Constitutionnel, et notamment de la liberté d'accès à la commande publique. Pour eux, l'État ne peut pas privatiser ADP s'il maintient l'éternité.

« L'APE en a complètement conscience et travaille sur une limitation de la durée d'exploitation », explique un connaisseur du dossier. Autrement dit, l'État planche sur un système de licence ou de concession qui serait, à l'issue du contrat, renouvelé ou remis en jeu, voire repris par l'État.

Pas si simple pour autant. La disparition de l'éternité n'est pas sans poser problème. En impactant négativement la valeur d'ADP, elle pénaliserait les actionnaires minoritaires actuels qu'il faudrait indemniser. Le montant de l'indemnisation dépendrait évidemment de la durée de la concession. Plus celle-ci sera longue (entre 50 et 99 ans, comme pour Eurotunnel), plus la perte de valeur serait faible.
Offre publique d'achat

Reste à savoir qui indemniserait les actionnaires minoritaires. Deux possibilités pour cela. "Soit l'État, soit l'acquéreur, et dans cette deuxième option, à travers une offre publique d'achat (OPA) dont le montant inclurait une prime correspondant à la perte de valeur liée à l'abandon du principe d'éternité", explique-t-on à La Tribune.

Un tel scénario passe nécessairement par la cession d'un bloc d'actions d'au moins 30% du capital d'ADP correspondant au seuil à partir duquel un actionnaire doit lancer une OPA sur l'ensemble du capital. Si l'État cède par exemple 20 % en deux blocs, aucun des acquéreurs ne détiendrait 30 % du capital et ne pourrait par conséquent lancer une OPA. Si l'État ne veut pas se lancer dans cette voie, il devra donc prendre à sa charge l'indemnisation des actionnaires minoritaires. Ce qui paraît peu probable. Pour l'heure néanmoins, l'État n'a pas encore tranché sur la façon dont il compte s'y prendre.

Aujourd'hui, ADP vaut 16 milliards d'euros en Bourse. Selon un proche du dossier cité par Reuters mi-décembre, la valorisation pourrait grimper à 25 milliards d'euros (dette comprise) en cas de privatisation.

FT : Anonymous ‘whistleblower’ claims ‘rampant manipulation’ of Vix index

Anonymous ‘whistleblower’ claims ‘rampant manipulation’ of Vix index
Cboe says the claims ‘lack credibility’

A self-professed whistleblower has contacted US regulators alleging manipulation of the Vix, a volatility index at the heart of last week’s market turmoil.

The Vix, run by the Chicago Board Options Exchange, last week spiked to levels twice its long term average following a long period of calm, stinging any investors that had used it to bet against wobbles in stock markets.

An alleged flaw in the Cboe’s volatility index “allows trading firms with sophisticated algorithms to move the Vix up or down by simply posting quotes on S&P options and without needing to physically engage in any trading or deploying any capital,” lawyers for the whistleblower claim in a letter to US financial watchdogs the Securities Exchange Commission and the Commodity Futures Trading Commission.


The lawyers from Washington-based Zuckerman Law say they represent an “anonymous whistleblower who has held senior positions at some of the largest investment firms in the world”.

The lawyers allege that the “market manipulation scheme” had exacerbated last week’s losses for investors in financial products that made profits when the Vix was low but lost value when Vix levels rose.


Credit Suisse closed one such exchange-traded product, once worth $2.2bn, last week after the instrument lost 96 per cent of its value in the equities sell-off. Nomura, a Japanese bank, also shuttered a similar product.

The Zuckerman lawyers told regulators “we contend that the liquidation of the Vix [exchange-traded products] last week was not due solely to flaws in the design of these products, but instead was driven largely by a rampant manipulation of the Vix index.”

The Cboe dismissed the claims: “This letter is replete with inaccurate statements, misconceptions and factual errors, including a fundamental misunderstanding of the relationship between the Vix Index, Vix futures and volatility” in exchange-traded products, it said in a statement.

“As a result of these errors, we feel the conclusionary statements contained in this letter lack credibility.”

>>> Kone unlikely to be interested in ThyssenKrupp or Toshiba lift operations –

Kone unlikely to be interested in ThyssenKrupp or Toshiba lift operations

Kone [HEL: KNEBV], the Finnish lift maker is unlikely to be interested in the lift operations of the German ThyssenKrupp [ETR: TKA] or Japanese Toshiba [TYO: 6502], according to Talouselama.
In an unsourced analysis about the company’s prospects for investors, the item said that for a couple of years, Kone has been rumoured to be interested in acquiring the lift operations of the ThyssenKrupp or Toshiba.
In the last few years, the company has been focusing its M&A on smaller service companies and instead of wider consolidation, it is more likely that Kone's business will benefit from the rise in global economy, the item noted.

(Exane) Telecom Equipment : Light at the end of the tunnel


* 5G timelines are accelerating globally
With all major US operators recently announcing 5G network rollouts in 2019 (and some in H2
2018), and with China, South Korea and Japan continuing to push their 5G ambitions forward, we
reiterate our view that 2019 will be the first year of 5G, not 2020. Governments globally are looking
to incentivise and accelerate 5G deployments in order to ensure economic competitiveness.

* The sector may bottom sooner than expected
Six months ago, industry forecasters had the mobile equipment market returning to growth in 2021.
That has now been brought forward to 2020, and we believe that 2019 may actually see a return to
growth. That would make 2018 the bottom of this post 4G cycle.

* 5G acceleration is putting a strain on R&D budgets
In September, we warned that Nokia would likely have to raise its R&D spend to match Ericsson
and others, and to prepare for 5G. Since then, we have seen consensus Nokia Networks 2018 non
IFRS EBIT fall ~40%. Nokia has also hiked its guidance for swap costs by EUR500m and for cash
restructuring by EUR100m in 2017-19, and also guided for 2018 capex to be more than EUR200m
higher than in 2016. ZTE and Huawei have also recently raised 5G R&D spending intentions. While
a 2019 recovery is increasingly possible, H1 2018 will likely remain difficult for the industry.

* Remain selective. Prefer Ericsson over Nokia
We believe 2018 will see market share gains by Ericsson, which is replacing Nokia in some
Vodafone, China Mobile, Deutsche Telekom footprint, and we now believe Sprint as well.
Ericsson’s expanding gross margins in H2 2017, expected 2018 improvements, and lack of non
IFRS swap charges, indicate it is not winning on price but rather on technology, as we have
argued. Nokia’s 10.5x 2018 EV/EBIT multiple does not allow for this risk, or for Nokia’s poor cash
flow, in our view. Ericsson has made significant progress on its turnaround (mainly on the balance
sheet in 2017). Borje Ekholm’s gross margin plan is already showing progress, and Ronnie Leten’s
arrival as Chairman should help drive operating margin improvement acceleration in H2.